Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New inhibitors of cyclin-dependent kinase 9 patented by Novartis

April 5, 2011

Novel microtubule-disrupting agents claimed

April 5, 2011

Glenmark Pharma begins IND-enabling studies for GBR-401

April 5, 2011

Algeta and Genzyme to collaborate on new approach to cancer treatment

April 4, 2011

IPI-926 reduces tumor growth in vivo and advances through clinical development

April 4, 2011

Eisai and PRISM collaborate on inhibitors of complex between CREB-binding protein and catenin beta-1

April 4, 2011

Polaris Pharma begins pivotal studies of ADI-PEG 20

April 4, 2011

New inhibitors of dual specificity protein kinase TTK presented

April 4, 2011

Novel HSP 90 inhibitors synthesized at Nerviano Medical Sciences

April 4, 2011

Combination of HER2 and VEGF peptidomimetics block angiogenesis and tumor cell growth

April 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...